Citation: M. Dathe, Antibacterial and hemolytic activity of amphipathic helical peptides, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 1-26
Citation: Y. Shai, Bacterial membrane as a target for a novel class of diastereomers of cytolytic peptides, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 27-44
Citation: Y. Cajal et Mk. Jain, Bee venom toxicity - Synergistic action of melittin on interfacial hydrolysis by phospholipase A(2), MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 45-62
Citation: J. Fuchs, Environmental effects on skin lipids and impairment of barrier function, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 77-93
Citation: Y. Shinohara et H. Terada, Uncouplers of oxidative phosphorylation - Activities and physiological significance, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 107-126
Citation: La. Balakireva et My. Balakirev, Transfection of eukaryotic cells with bipolar cationic derivatives of tetraether lipid, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 153-166
Citation: Ja. Mccann et Wd. Picking, Cholera toxin conformational changes associated with changes in membrane structure, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 167-181
Citation: Ab. Vaidya et al., Parasite mitochondrial membrane functions as targets for chemotherapy, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 183-200
Authors:
Seydel, U
Ulmer, AJ
Uhlig, S
Rietschel, ET
Citation: U. Seydel et al., Lipopolysaccharide - A membrane-forming and inflammation-inducing bacterial macromolecule, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 217-252
Citation: B. Kadenbach et S. Arnold, 3,5-diiodothyronine binds to subunit Va of cytochrome c oxidase - Possiblemechanism of short-term effects of thyroid hormones, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 271-281
Authors:
Somwar, R
Yaworsky, K
Sweeney, G
Ramlal, T
Tong, P
Khayat, Z
Klip, A
Citation: R. Somwar et al., Regulation of glucose transport by insulin in muscle and fat cells - Translocation and activation of glucose transporters, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 283-301
Citation: W. Hemrika et al., Glucose-6-phosphatase - A member of the newly identified HPP superfamily that consists of histidine phosphatases and vanadium-containing peroxidases and consequences for membrane topology, active site, and reaction mechanism, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 303-333
Citation: Da. Butterfield, Alzheimer's amyloid beta-peptide-associated oxidative stress - Brain membrane lipid peroxidation and protein oxidation, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 335-352
Authors:
Boeve, CMA
Cupers, P
Van Leuven, F
Annaert, W
De Strooper, B
Citation: Cma. Boeve et al., Membrane orientation of the Alzheimer's disease - Associated presenilins, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 353-368
Authors:
Ebener, U
Wehner, S
Rietschel, C
Cakmak, H
Niegemann, E
Eishold, M
Citation: U. Ebener et al., Membrane structure analysis in apoptotic processes of leukemic blasts and leukemia-derived cell lines, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 369-385
Citation: M. Bestagno et O. Burrone, Use of monoclonal antibodies in cloning and identification of membrane antigens, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 387-408
Citation: Kw. Klinger et O. Ibraghimov-beskrovnaya, Polycystins - Membrane-associated proteins involved in autosomal dominant polycystic kidney disease, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 409-426
Authors:
Zimmer, G
Bernhorster, M
Pilz, P
Schuchmann-Fix, J
Citation: G. Zimmer et al., Action of beta-agonists compared to cromoglycate on mononuclear cell membranes - Stabilizing or destabilizing?, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 427-437
Citation: M. Sugita et Jk. Foskett, Cystic fibrosis transmembrane conductance regulator - A chloride channel regulator of ion channels, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 439-459
Citation: Ab. Fisher, Role of Ca2+-independent lysosomal phospholipase A(2) in turnover of lung surfactant pospholipids, MEMBRANE STRUCTURE IN DISEASE AND DRUG THERAPY, 2000, pp. 461-478